ArticleBMC public health2025
Factors influencing rehabilitation costs for stroke inpatients in Shenzhen: a multicenter retrospective study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case-Control Analysis.CNS neuroscience & therapeutics · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundStroke is a leading cause of death and disability among Chinese residents, imposing a significant economic burden. This study aimed to analyze the current status and influencing factors of inpatient rehabilitation costs for stroke in Shenzhen, providing evidence to help reduce costs for patients with stroke in rehabilitation centers.
methodsThis multicenter retrospective study used data primarily collected from patient's medical records. We included patients admitted to the rehabilitation departments of public and private hospitals in Shenzhen from January 1, 2019, to October 31, 2021, who met the diagnostic criteria for stroke. After data cleaning, we collected information on hospital demographics, diagnoses, functional impairments, length of stay, and hospitalization costs. Multiple linear regression analysis was used to create a path analysis model to assess the direct and indirect effects of various factors on total hospitalization and average daily expenditures.
resultsThe study included 2638 patients with stroke from 22 hospitals in Shenzhen, with 69.6% males and an average age of 59.2 years. Ischemic and hemorrhagic strokes accounted for 56% and 44% of the cases, respectively. The median total hospitalization costs were 27,306.64 Chinese Yuan (CNY) (4022.79 USD) for ischemic stroke and 32,188.25 CNY (4022.79 USD) for hemorrhagic stroke, while the average daily costs were 848.64 CNY (125.87 USD) and 828.23 CNY (125.87 USD), respectively. The median length of stay (LOS) was 30 days for patients with ischemic stroke and 41 days for patients with hemorrhagic stroke. Rehabilitation accounted for the highest cost category (64% and 68%, respectively). Path analysis revealed that LOS was the primary direct factor influencing total hospitalization costs, while hospital grades, functional impairment levels, disease stage, and age were indirect factors. For average daily costs, the primary direct influencing factor was hospital grades, with functional impairment levels, disease stage, and age as indirect factors.
conclusionsPatients with stroke in Shenzhen face significant financial burden. The government should continuously promote the construction of a three-tiered rehabilitation system and hierarchical LOS management to provide systematic and sustainable medical services. Daily costs should be stratified based on functional impairment levels, disease stage, and age to guide the reform of precision bed-day medical insurance payments for stroke rehabilitation.
trial registrationThe study protocol was registered in the Chinese Clinical Trial Registry (ChiCTR-2000034067, Registration date: 22 June 2020, http://www.chictr.org.cn/showproj.aspx?proj=54770 ).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.